Wells Fargo raised the firm’s price target on Doximity (DOCS) to $65 from $62 and keeps an Equal Weight rating on the shares. The firm says the Q1 beat and raise reflects solid business momentum and echoes conclusions from its preview ahead of earnings print. AI strategy is taking shape as debuted AI Scribe and acquired Pathway AI reinforces platform engagement and monetization prospects, Wells adds.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DOCS:
- Doximity price target raised to $59 from $50 at Canaccord
- Doximity’s Strong Q1 and AI Innovations Drive Buy Rating Despite Growth Concerns
- Doximity Reports Strong Q1 Earnings with Revenue Growth
- Closing Bell Movers: Expedia, TripAdvisor jump on Q2 earnings beats
- Doximity’s Strong Financial Performance and Strategic AI Acquisition Justify Buy Rating